S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 121 to 167 of 167

Issue Date	Title / Author(s) / Citation	File
2015-01	ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Ham, Hye Seon; Lee, Kyung Hun; Kim, Tae Yong; Kim, Yu Jung; Oh, Do-Youn; Kim, Jee Hyun; Han, Wonshik; Jang, In-Jin; Kim, Tae-You; Park, In Ae; Noh, Dong Young Cancer Science, Vol.106 No.1, pp.86-93	DOI
2015-01	TGF-β suppresses COX-2 expression by tristetraprolin-mediated RNA destabilization in A549 human lung cancer cells Kang, Soyeong; Min, Ahrum; Im, Seock-Ah; Song, Sang-Hyun; Kim, Sang Gyun; Kim, Hyun-Ah; Kim, Hee-Jun; Oh, Do-Youn; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.1, pp.101-109	DOI
2015-03	Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells Min, Ahrum; Im, Seock-Ah; Kim, Debora Keunyoung; Song, Sang-Hyun; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O'Connor, Mark J.; Bang, Yung-Jue Breast Cancer Research, Vol.17, p. 33	view file DOI
2015-04	Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatectomy for pancreatic adenocarcinoma Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Joo, Ijin; Ha, Sung W. Cancer Research and Treatment, Vol.47 No.2, pp.274-281	DOI
2015-06	A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer Kim, Jin Won; Choi, In Sil; Kim, Yu Jung; Lee, Kyung-Hun; Lee, Keun-Wook; Kim, Tae-Yong; Han, Sae-Won; Kim, Jee Hyun; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue; Im, Seock-Ah; Oh, Do-Youn Cancer Chemotherapy and Pharmacology, Vol.75 No.6, pp.1175-1182	DOI
2015-06	Optimal patient selection for trastuzumab treatment in HER2-positive advanced gastric cancer Ock, Chan-Young; Lee, Keun-Wook; Kim, Jin Won; Kim, Jin-Soo; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue; Oh, Do-Youn Clinical Cancer Research, Vol.21 No.11, pp.2520-2529	DOI
2015-07	Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX Lee, Dae-Won; Han, Sae-Won; Cha, Yongjun; Rhee, Ye Young; Bae, Jeong Mo; Cho, Nam-Yun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Kang, Gyeong Hoon; Kim, Tae-You Clinical Epigenetics, Vol.7, p. 63	view file DOI
2015-08	Metabolic characteristics of advanced biliary tract cancer using F-18-fluorodeoxyglucose positron emission tomography and their clinical implications Cho, Kyoung-Min; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncologist, Vol.20 No.8, pp.926-933	DOI
2015-10	Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients Lee, Dae-Won; Han, Sae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, Ji Won; Ryoo, Seung-Bum; Jeong, Seung-Yong; Kang, Gyeong Hoon; Park, Kyu Joo; Kim, Tae-You BMC Cancer, Vol.15, p. 690	view file DOI
2015-10	Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Mi-Jung; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Yuasa, Miyuki; Yanagihara, Yasuo; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.4, pp.607-615	DOI
2015-10	Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index Choi, Younak; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue PLoS ONE, Vol.10 No.10, p. e0139749	DOI
2015-10	Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma Lee, Kyung-Hun; Lee, Kyoung-Bun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Yi, Nam-Joon; Lee, Kwang-Woong; Suh, Kyung-Suk; Jang, Ja-June; Bang, Yung-Jue BMC Cancer, Vol.15, p. 721	view file DOI
2015-10	The prognostic importance of the number of metastatic lymph nodes for patients undergoing curative resection followed by adjuvant chemoradiotherapy for extrahepatic bile duct cancer Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Kwon, Jeanny; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Journal of Gastrointestinal Surgery, Vol.19 No.10, pp.1833-1841	DOI
2015-11	The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn American Journal of Cancer Research, Vol.5 No.11, pp.3376-3388
2016-01	The impact of diabetes mellitus and metformin treatment on survival of patients with advanced pancreatic cancer undergoing chemotherapy Choi, Younak; Kim, Tae-Yong; Oh, Do-Youn; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.1, pp.171-179	DOI
2016-01	Phase I study of CKD-516, a novel vascular disrupting agent, in patients with advanced solid tumors Oh, Do-Youn; Kim, Tae-Min; Han, Sae-Won; Shin, Dong-Yeop; Lee, Yun Gyoo; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Tae-You; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.1, pp.28-36	DOI
2016-01	More accurate prediction of metastatic pancreatic cancer patients' survival with prognostic model using both host immunity and tumor metabolic activity Choi, Younak; Oh, Do-Youn; Park, Hyunkyung; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue PLoS ONE, Vol.11 No.1, p. A58	DOI
2016-03	Survival outcomes according to adjuvant treatment and prognostic factors including host immune markers in patients with curatively resected ampulla of vater cancer Ha, Hye Rim; Oh, Do-Youn; Kim, Tae-Yong; Lee, KyoungBun; Kim, Kyubo; Lee, Kyung-Hun; Han, Sae-Won; Chie, Eui Kyu; Jang, Jin-Young; Im, Seock-Ah; Kim, Tae-You; Kim, Sun-Whe; Bang, Yung-Jue PLoS ONE, Vol.11 No.3, p. e0151406	DOI
2016-03	Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy Kim, Hyori; Youk, Jeonghwan; Yang, Yaewon; Kim, Tae-Yong; Min, Ahrum; Ham, Hye-Seon; Cho, Seongcheol; Lee, Kyung-Hun; Keam, Bhumsuk; Han, Sae-Won; Oh, Do-Youn; Ryu, Han Suk; Han, Wonshik; Park, In Ae; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Journal of Cancer Research and Clinical Oncology, Vol.142 No.3, pp.707-714	DOI
2016-04	Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer Ock, Chan-Young; Oh, Do-Youn; Lee, Joongyub; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Gastric Cancer, Vol.19 No.2, pp.597-606	DOI
2016-04	Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications Ock, Chan-Young; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.19 No.2, pp.421-430	DOI
2016-06	Prognostic role of body mass index in advanced small bowel adenocarcinoma patients receiving palliative chemotherapy Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Nutrition and Cancer, Vol.68 No.5, pp.750-755	DOI
2016-07	Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer Cha, Yongjun; Kim, Kyung-Ju; Han, Sae-Won; Rhee, Ye Young; Bae, Jeong Mo; Wen, Xianyu; Cho, Nam-Yun; Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Kang, Gyeong Hoon; Kim, Tae-You British Journal of Cancer, Vol.115 No.2, pp.164-171	DOI
2016-07	Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses Yang, Yaewon; Im, Seock-Ah; Keam, Bhumsuk; Lee, Kyung-Hun; Kim, Tae-Yong; Suh, Koung Jin; Ryu, Han Suk; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young BMC Cancer, Vol.16, p. 515	DOI
2016-07	Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX Kim, Mi-Jung; Han, Sae-Won; Lee, Dae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Kim, Se Hyung; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Research and Treatment, Vol.48 No.3, pp.990-997	DOI
2016-07	Concurrent chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: A retrospective cohort study Choi, Younak; Oh, Do-Youn; Kim, Kyubo; Chie, Eui Kyu; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Ha, Sung Whan; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.3, pp.1045-1055	DOI
2016-07	Src as a Therapeutic Target in Biliary Tract Cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.15 No.7, pp.1515-1524	DOI
2016-08	Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.39 No.4, pp.346-349	DOI
2016-09	Therapeutic implication of HER2 in advanced biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Cha, Yongjun; Ha, Hyerim; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Oncotarget, Vol.7 No.36, pp.58007-58021	DOI
2016-11	Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy Ha, Hyerim; Nam, Ah-Rong; Bang, Ju-Hee; Park, Ji-Eun; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Oncotarget, Vol.7 No.47, pp.76604-76612	DOI
2016-11	TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials Lee, Dae-Won; Jang, Myoung-Jin; Lee, Kyung-Hun; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You British Journal of Cancer, Vol.115 No.10, pp.1201-1205	DOI
2017-01	Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.1, pp.164-174	DOI
2017-01	Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.2, pp.2329-2341	DOI
2017-03	Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Lee, Joongyub; Bang, Ju-Hee; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.2, pp.254-262	DOI
2017-04	Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea Beom, Seung Hoon; Oh, Jisu; Kim, Tae-Yong; Lee, Kyung-Hun; Yang, Yaewon; Suh, Koung Jin; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.2, pp.454-463	DOI
2017-04	Phosphorylated Akt expression as a favorable prognostic factor for patients undergoing curative resection and adjuvant chemoradiotherapy for proximal extrahepatic bile duct cancer Kim, Byoung Hyuck; Kim, Kyubo; Min, Hye Sook; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Jang, Ja-June; Ha, Sung W. American Journal of Clinical Oncology, Vol.40 No.2, pp.158-162	DOI
2017-06	Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication Park, Seongyeol; Ha, Seunggyun; Kwon, Hyun Woo; Kim, Woo Hyoung; Kim, Tae-Yong; Oh, Do-Youn; Cheon, Gi Jeong; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.58 No.6, pp.899-904	DOI
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2017-08	Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer Jo, Jaemin; Kwon, Hyun Woo; Park, Seongyeol; Oh, Do-Youn; Cheon, Gi Jeong; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.58 No.8, pp.1255-1261	DOI
2017-10	Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79441-79452	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2019-08	A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors Oh, Do-Youn; Lee, Keun-Wook; Han, Sae-Won; Kim, Jin Won; Shin, Jung-Won; Jo, Seong-Jin; Won, Jonghwa; Hahn, Seokyung; Lee, Howard; Kim, Woo Ho; Bang, Yung-Jue Oncologist, Vol.24 No.8, pp.1037-e636-+	DOI
2020-01	Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study Yoo, Shin Hye; Kang, Seo Young; Cheon, Gi Jeong; Oh, Do-Youn; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.61 No.1, pp.33-39	DOI
2021-05	A target-mediated drug disposition population pharmacokinetic model of GC1118, a novel anti-EGFR antibody, in patients with solid tumors Chung, Tae Kyu; Lee, Hyun A.; Park, Sang-In; Oh, Do-Youn; Lee, Keun-Wook; Kim, Jin Won; Kim, Jee Hyun; Woo, Ahmi; Lee, Su Jin; Bang, Yung-Jue; Lee, Howard Clinical and Translational Science, Vol.14 No.3, pp.990-1001	DOI
2021-10	Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer Lee, Kyung-Hun; Chie, Eui Kyu; Im, Seock-Ah; Kim, Jee Hyun; Kwon, Jihyun; Han, Sae-Won; Oh, Do-Youn; Jang, Jin-Young; Kim, Jae-Sung; Kim, Tae-You; Bang, Yung-Jue; Kim, Sun Whe; Ha, Sung W. Cancer Research and Treatment, Vol.53 No.4, pp.1096-1103	DOI

1 2 3